Latest Breaking News On - வீரம் முயற்சிகள் - Page 1 : comparemela.com

(1) PRS stratifies disease risk and brings precision medicine into clinical routine Allelica, a leading genomics software company specialising in developing polygenic risk scores (PRSs) for common diseases, today announced that the company has raised $1.75 million in a seed financing round led by Valor Ventures, Sternberg Health, Pi Campus, as well as strategic business angels also participated in the round. As part of the transaction, Valor Ventures General Partner Gary Peat has joined the Allelica board of directors and Allelica has relocated its headquarters to New York City. The proceeds of the financing will be used to advance clinical integration of Allelica s PRS software into healthcare systems in the US. A PRS is a measurement of a person s risk of disease based on their genes and is based on combining the effects of a large number of genetic variants across the genome. This information can be used to stratify individuals based on their risk of disease. By combining PRS

New yorkUnited statesGiordano bottKostenloser wertpapierhandelMike sinclairSternberg healthValor venturesValor ventures general partner gary peatGary peatGeneral partnerபுதியது யார்க்ஒன்றுபட்டது மாநிலங்களில்ஜியோர்டானோ பாட்டில்மைக் சின்க்ளேர்ஸ்டென்பெர்க் ஆரோக்கியம்வீரம் முயற்சிகள்